Lessons from Two Trials of Mycophenolate Mofetil in Myasthenia Gravis

• DOI: 10.1196/annals.1405.031
• Publication Date: 2008-06-20T23:23:28Z
• Authors: Donald B. Sanders; Zaeem A. Siddiqi
• Keywords: Mycophenolate

Two randomized controlled trials of mycophenolate mofetil (MMF) in the treatment myasthenia gravis (MG) were recently completed. Although neither study demonstrated efficacy MMF population patients studied, there are valuable lessons way these studies developed and performed. After reviewing design results trials, we discuss possible reasons leading to negative learned, which should be useful for future clinical MG.